Are there any alternative treatments?
During the study you should continue to take any other treatments you may have been given to treat your kidneys. Your local doctors will be asked to ensure they continue to treat your other medical problems according to guidance produced by experts at a local, national or international level.
If you are already taking any medication with the name ending in -flozin [such as dapagliflozin or canagliflozin), you will have to stop this and switch to empagliflozin to be able to join this study.
Your local study doctors will be asked to review the information collected at your first study visit (the screening visit) and approve your entry into the trial.
They will consider whether you may need to start a treatment called finerenone, which is similar to BI 690517, and can be used in certain patients with diabetes and chronic kidney disease.
If you are taking or are recommended to start finerenone (or any similar type of drug such as eplerenone or spironolactone), you will not be able to take part in EASi-KIDNEYTM.